- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04372043
Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.
The term "sleep hygiene" refers to a series of healthy sleep habits that can improve the ability to fall asleep. These habits are the most effective long-term treatment for people with chronic insomnia. The "Sleep Hygiene Index" is a 13-item questionnaire that evaluates these habits. We are in the process of validation of this questionnaire in the arabic language.
We will evaluate these habits in the Lebanese population during the COVID-19 confinement period.
Study Overview
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Beirut, Lebanon, 1100
- Saint Joseph University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Lebanese living in Lebanon, 18 YO and over, understanding written english or arabic.
Exclusion Criteria:
- Not having the inclusion criteria.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Lebanese population
The "Sleep Hygiene Index" with other demographic questions will be applied to the Lebanese population.
|
"Sleep Hygiene Index" and demographic questions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Sleep Hygiene
Time Frame: 30/04/2020 to 30/12/2020
|
30/04/2020 to 30/12/2020
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Jeanine El Helou, MD, MSc, USJ
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CEHDF1650
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.